- Following recent child deaths linked to contaminated cough syrups , the Central Drugs Standard Control Organisation (CDSCO) has launched the Online National Drug Licensing System (ONDLS) to monitor and regulate high-risk pharmaceutical solvents.
Purpose and Function:
-
The ONDLS portal enables real-time tracking of solvent batches used in drug manufacturing.
-
All state and union territory drug controllers have been directed to implement the system for licensing and compliance.
-
Manufacturers must upload detailed batch data , including certificates of analysis and buyer information , to ensure transparency and traceability.
-
Unverified or unlicensed solvent batches will be blocked from market entry .
Background:
-
The move follows child fatalities in Madhya Pradesh caused by syrups contaminated with diethylene glycol (DEG) .
-
Investigations revealed lapses in ingredient sourcing and quality control .
-
The World Health Organization (WHO) had issued a global alert over such contamination risks in paediatric medicines.
High-Risk Solvents Identified:
-
Ten solvents under scrutiny include glycerin, propylene glycol, sorbitol, maltitol, ethyl alcohol, and hydrogenated starch hydrolysate .
-
These ingredients are safe when pure but can become toxic if adulterated with industrial-grade chemicals.
Regulatory Action:
-
Directive issued by Dr Rajeev Singh Raghuvanshi , Drugs Controller General of India .
-
Decision followed a high-level review meeting chaired by the Union Health Secretary on October 5, 2025 .
-
Existing manufacturers must migrate to the new system under an “old licence management” module for continued compliance.
Key GK Facts:
-
DEG contamination has caused poisoning incidents in India since the 1970s , prompting multiple reforms.
-
The CDSCO , under the Ministry of Health and Family Welfare , is India’s apex drug regulatory authority .
-
ONDLS was initially designed to digitise licensing and compliance across India’s pharmaceutical industry.
Significance:
-
Ensures end-to-end traceability of pharmaceutical solvents.
-
Strengthens drug quality oversight and prevents future contamination incidents.
-
Reinforces India’s commitment to pharmaceutical safety and public
Month: Current Affairs - October 24, 2025
Category: Public Health and Drug Safety Measures